| |
| | Duloxetine Clinical Study Results Show Improvement in Stress Urinary Incontinence in Women (Site not responding. Last check: 2007-10-12) |
 | | Clinical studies of duloxetine for the treatment of SUI have shown the most commonly reported adverse events (incidence of > 5 percent and at least twice the placebo rate) reported by patients receiving duloxetine have been nausea, dry mouth, fatigue, insomnia, constipation, headache, dizziness, somnolence (drowsiness) and diarrhea.7 |
 | | Duloxetine is a balanced dual reuptake inhibitor of the neurotransmitters serotonin and norepinephrine,8 which play a key role in normal urethral sphincter closure, the weakening of which can result in SUI. |
 | | By increasing neurotransmitter concentration, duloxetine is believed to increase the tone and contraction of the external urethral sphincter,9 which helps prevent accidental urine leakage during physical activities such as sneezing, coughing, laughing, lifting or exercise. |
| www.medilexicon.com /medicalnews.php?newsid=11404 (1187 words) |
|